Skip to main content
OpenTrials
Completed

NCT Number: NCT05375578

Urdu Translation of Wayfinding Questionnaire for Stroke Patients

Descriptive analytical study to translate WQ in Urdu Language. The WQ is in English Language the name of the author of WQ is Van der Ham Et al and firstly introduced in 2013. The reliability of this English tool is 0.70 to 0.80 it has been translated in various Languages i.e Hungarian, Dutch and Chinese and suffering from stroke. But it was not translated in Urdu Language. No such study has been previously conducted in Pakistan region which translates the scale and follows the proper cross-cultural adaptation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

45 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital

Lahore, Pakistan(Punjab_, 54000, Pakistan

About this study

For resolving such problem WQ play pivotal role in accessing navigation problem of stroke patients it is a very reliable tool for accessing navigation issue. The scale consists of 22 items. All the items dated from 01 to 07 in which stroke patients are accessed. The patients who are taken in the study age from 18 to 65 years. As the WQ is a well-developed measurement scale for accessing navigation in stroke patients. It is meaningful to validate its Urdu version. The translation and cultural adaptation process would start after obtaining approval from the developer of the original WQ. This would be done according to bitten guidelines. The purpose will be to gain uniformity in the translation of both the target Language and source Language. This will involve 5 steps which is forward translation, synthesis 1, back translation, synthesis 2 and pallet testing. The second step would be done according to the Beaton guidelines in which psychometric properties will be measured that is internal consistency, test retest reliability, Discriminant validity, Convergent Validity, Content Validity and Factor analysis

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age group 45-65 years
  • Male and Female.
  • Both ischemic and hemorrhagic stroke
  • Patient may have First or Recurrent Stroke.
  • Recovery is > 6 months of First Stroke event
  • MMSE score > 25

Exclusion criteria

  • Population suffering from Severe Global Aphasia.
  • Population suffering from Severe Mobility Problem.
  • Any other neurological disease dementia
  • Alzheimer's
  • Cognitive Decline before Stroke

Treatment and study plan

Primary outcomes

  1. Wayfinding Questionnaire

    Time frame: 8 months

    For resolving such problem WQ play pivotal role in accessing navigation problem of stroke patients it is a very reliable tool for accessing navigation issue. The scale consists of 22 items. All the items rated from 1 to 7 in which stroke patients are assessed. The patients who are taken in the study age from 45 to 65 years.

Secondary outcomes

  1. Reliability of translated version of WQ

    Time frame: 8 months

    To determine the reliability of cross-culturally adapted and translated WQ in the patients with stroke.

    Reliability or reproducibility reference to a measure to produce the same results when administered at to intervals between different visits of the patients. Thus this will be measured through test re-test reliability

  2. Validity of translated version of WQ

    Time frame: 8 months

    To determine the validity of cross-culturally adapted and translated WQ for stroke patients in Urdu language

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Urdu Translation and Cross Cultural Validation of Wayfinding Questionnaire for Stroke Patients

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
May 16, 2022
Registry last updated
Dec 12, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.